Our protein microarray analyses revealed significant alterations in the expression of CXCL5, with the CXCL5/CXCR2 axis playing a pivotal role in driving tumor cell deterioration, as documented in previous studies 45, 46. The gene discussed is CXCL5; the disease is neoplasm.